Paclitaxel maculopathy

Arch Ophthalmol. 2007 May;125(5):709-10. doi: 10.1001/archopht.125.5.709.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / secondary
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Breast Neoplasms / radiotherapy
  • Drug Therapy, Combination
  • Female
  • Fluorescein Angiography
  • Humans
  • Macular Edema / chemically induced*
  • Macular Edema / diagnosis
  • Middle Aged
  • Paclitaxel / adverse effects*
  • Tomography, Optical Coherence
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Phytogenic
  • Trastuzumab
  • Paclitaxel